Nav: Home

Findings suggest overuse of chemotherapy among younger patients with colon cancer

January 25, 2017

Young and middle-aged patients with colon cancer are nearly 2 to 8 times more likely to receive postoperative chemotherapy than older patients, yet study results suggest no added survival benefit for these patients, according to a study published online by JAMA Surgery.

Colorectal cancer is the third leading cause of cancer death in the United States, with an expected 134,490 new cases and 49,190 deaths in 2016. While incidence and mortality rates among adults 50 years and older have decreased in the United States in recent years, the same trend has not been observed for patients 20 to 49 years of age. Treatment options for patients with young-onset colon cancer remain to be defined and their effects on prognosis are unclear.

Kangmin Zhu, Ph.D., M.D., of the John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, Md., and colleagues examined whether age differences in receiving chemotherapy matched survival gains among patients diagnosed as having colon cancer in an equal-access health care system. The study was based on data from the U.S. Department of Defense's Central Cancer Registry and Military Heath System medical claims databases. There were 3,143 patients ages 18 to 75 years with histologically confirmed primary colon cancer diagnosed between 1998 and 2007.

Of the patients, 59 percent were men. Young (18-49 years) and middle-aged (50-64 years) patients were two to eight times more likely to receive postoperative systemic chemotherapy compared with older patients (65-75 years), regardless of tumor stage at diagnosis. Young and middle-aged adults were 2.5 times more likely to receive multi-agent chemotherapy regimens. While young and middle-aged adults who only underwent surgery had better survival compared with older patients, no significant differences in survival were seen between young/middle-aged and older patients who received surgery plus postoperative systemic chemotherapy.

"Most of the young patients received post-operative systemic chemotherapy, including multi-agent regimens, which are currently not recommended for most patients with early-stage colon cancer. Our findings suggest overtreatment of young and middle-aged adults with colon cancer," the authors write.
-end-
(JAMA Surgery. Published online January 25, 2017.doi:10.1001/jamasurg.2016.5050. This study is available pre-embargo at the For The Media website.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Colon Cancer Articles:

Turning colon cancer cells around
Using a modified natural substance along with current approaches could improve colon cancer treatment, according to findings by University of California, Irvine biologists.
Uncovering the pathway to colon cancer
The hidden world of genetic changes, or mutations, in healthy colon tissue has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators.
Colon cancer growth reduced by exercise
Exercise may play a role in reducing the growth of colon cancer cells according to new research published in The Journal of Physiology.
Towards a better understanding of how colon cancer develops and progresses
Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer.
New target protein for colon cancer identified
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the disease.
Colon cancer -- Targeting tumor cell plasticity
Cell type switch helps colon cancer evade treatment, a study suggests.
A bacterial duo linked to colon cancer
Scientists have identified a combination of bacteria that appears to increase the risk of colon cancer.
New model could speed up colon cancer research
Using the CRISPR gene editing system, MIT researchers have shown they can generate colon tumors in mice that very closely resemble human colon tumors, an advance that should allow scientists to learn more about how the disease progresses and also help them test potential new drugs.
Are dialysis patients being over-screened for colon cancer?
Colonoscopies are being performed more often on healthier dialysis patients than on those with more limited life expectancies; however, overall, dialysis patients are being screened at a much higher rate relative to their life expectancy than their counterparts without kidney failure.
The importance of the glutamine metabolism in colon cancer
The importance of glutamine was made clear as a colon cancer specific metabolism.
More Colon Cancer News and Colon Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.